Redeye updates its estimates of Ependion and discusses both the most recent report and Beijer Electronics’ strategic review in depth. Q1 2024 was almost perfectly in line with our estimates and showed a good sequential uptick. However, the near-term appears to be quite uncertain and Westermo’s ongoing cost reduction to adjust for volumes carries a signal value. On the other hand, the structural growth stays intact and Ependion is well-positioned in the medium-to long-term. Beijer Electronics’s strategic review was such a confirmation.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/